<DOC>
	<DOCNO>NCT00640419</DOCNO>
	<brief_summary>The purpose study test investigational medication ABT-089 safe effective treatment child Attention Deficit Hyperactivity Disorder ( ADHD ) .</brief_summary>
	<brief_title>Safety Tolerability Study ABT-089 Children With Attention-Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Have voluntarily sign informed consent form . Meet diagnostic criterion attentiondeficit/hyperactivity disorder ( ADHD ) base detailed evaluation interview parent ( ) . Subject generally good health base medical history , physical examination , clinical lab test ECG . Subject weight least 37 pound ( 17 kg ) Female subject childbearing potential must negative urine pregnancy test screening baseline agree comply applicable contraceptive requirement . Subject swallow pill subject parent able keep require appointment clinic visit test , include blood draw examination . Subject current past diagnosis bipolar disorder , psychosis , autism , Asperger syndrome , pervasive developmental disorder , tic , Tourette syndrome , mental retardation , seizure disorder traumatic brain injury . Current diagnosis obsessivecompulsive disorder , eat disorder , anxiety disorder depressive disorder require treatment kind . Subject history , ongoing , serious medical problem . Subject history significant allergic reaction drug . Subject plan begin type behavioral psychotherapy treatment ADHD . Subject require ongoing treatment psychiatric medication .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>